A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
Clinical trial NCT00386152 · TERMINATED
Trial details
- NCT number
- NCT00386152
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.